Healthy Skepticism Library item: 6566

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Bayer asserts that we should use “Ciproxin first for difficult infections
MaLAM Australian News 1995; 3:(1):1-2

Abstract:

Widescale promotion for ciprofloxacin from Bayer has lead to inappropriate prescribing of this antibiotic in a number of settings.

Keywords:
*analysis/Australia/developed countries/Ciproxin/ciprofloxacin/Bayer/antibiotics/quality of information/ quality of prescribing/MaLAM/Medical Lobby for Appropriate Marketing/INFLUENCE OF PROMOTION: PRESCRIBING, DRUG USE/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPED COUNTRIES/PROMOTION IN SPECIFIC THERAPEUTIC AREAS: ANTIBIOTICS